Atara Biotherapeutics

Last updated: October 12, 2024

Isaac Ciechanover, CEO & President
Isaac Ciechanover, CEO & President
USA | Funding: $535.8M (+)

Website: http://www.atarabio.com/

Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, multiple sclerosis (MS).